In a groundbreaking move, O’Melveny has once again proven its expertise in the legal arena by spearheading a significant financial milestone in the healthcare sector. The prestigious law firm recently represented BenQ BM Holding Cayman Corp. (BenQ Holding, 2581.HK) in its highly anticipated initial public offering (IPO) on the Main Board of the Hong Kong Stock Exchange. With a total offering size of approximately HK$625 million (roughly US$80 million), this deal underscores O’Melveny’s ability to navigate complex international transactions seamlessly. But here’s where it gets even more intriguing: this marks the firm’s second Hong Kong IPO for a medical institution in 2025, following the successful launch of Bayzed Health Group earlier in the year. Is this a sign of a growing trend in healthcare companies going public, or just a coincidence?
BenQ Holding is no small player in the healthcare industry. As of 2024, it stands as the largest private for-profit general hospital group in East China by revenue. The group’s flagship hospitals, Nanjing BenQ Hospital and Suzhou BenQ Hospital, are powerhouses in their own right. Nanjing BenQ Hospital, in particular, ranks as the third-largest private for-profit general hospital in all of China by revenue—a testament to the group’s impact and scale. But here’s the part most people miss: In an era where healthcare accessibility and quality are under constant scrutiny, BenQ Holding’s IPO could signal a shift toward greater investment in private healthcare infrastructure. Or does it simply highlight the growing commercialization of medical services? We’d love to hear your thoughts in the comments.
The transaction was supported by a stellar lineup of financial institutions, with CICC and Citigroup acting as joint sponsors. Additional underwriters included CTBC Bank, Futu Securities, Livermore Holdings, TradeGo Markets, UOB Kay Hian Limited, and others, showcasing the broad confidence in BenQ Holding’s future prospects. O’Melveny’s role as both Hong Kong and U.S. counsel highlights its cross-border capabilities, a critical asset in today’s globalized market.
Leading the charge for O’Melveny were corporate partners Ke Geng and Ke Zhu, whose expertise in international corporate law was instrumental in the deal’s success. The core team also included counsel Si Shen and Jerry Gao, associate Madlyn Li, senior legal manager Alfred Li, and legal consultants Simon Xu, Audrey Zhan, and Cecilia Chen. Their collaborative effort ensured that every detail was meticulously addressed, from regulatory compliance to strategic structuring.
At O’Melveny, it’s not just about what we do—it’s about how we do it. Whether in boardrooms or courtrooms, across sectors and borders, our success is measured by yours. We’re committed to delivering premier legal services without compromising on exceptional client experience. Our goal? To ensure you never have to choose between top-tier lawyering and outstanding service. So, what’s your next big goal? Let’s achieve it together. Explore more about us at www.omm.com, dive into our firm at-a-glance here, and connect with us on LinkedIn, Facebook, Instagram, and YouTube.
For media inquiries, contact:
Brandon Jacobsen
O’Melveny & Myers LLP
+1 213 430 8024
bjacobsen@omm.com
Chris Schob
O’Melveny & Myers LLP
+86 21 2307 7000
cschob@omm.com
